Medexus Pharmaceuticals Announces Overnight Marketed Public Offering of Common Shares

NOT FOR DISTRIBUTION TO UNITED STATES

TORONTO and CHICAGO, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (“Medexus” or the “Company”) (TSX: MDP), is pleased to announce that it has launched an overnight marketed underwritten offering (the “Offering”) of common shares of the Company (the “Common Shares”).

Read more at globenewswire.com